139 related articles for article (PubMed ID: 12641328)
1. Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences.
Swanepoel E; Liebenberg W; Devarakonda B; de Villiers MM
Pharmazie; 2003 Feb; 58(2):117-21. PubMed ID: 12641328
[TBL] [Abstract][Full Text] [Related]
2. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
Liebenberg W; Dekker TG; Lötter AP; de Villiers MM
Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
[TBL] [Abstract][Full Text] [Related]
3. Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs.
Swanepoel E; Liebenberg W; de Villiers MM
Eur J Pharm Biopharm; 2003 May; 55(3):345-9. PubMed ID: 12754010
[TBL] [Abstract][Full Text] [Related]
4. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole.
de Villiers MM; Terblanche RJ; Liebenberg W; Swanepoel E; Dekker TG; Song M
J Pharm Biomed Anal; 2005 Jul; 38(3):435-41. PubMed ID: 15925244
[TBL] [Abstract][Full Text] [Related]
5. Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation.
Agatonovic-Kustrin S; Glass BD; Mangan M; Smithson J
Int J Pharm; 2008 Sep; 361(1-2):245-50. PubMed ID: 18555626
[TBL] [Abstract][Full Text] [Related]
6. A discriminating dissolution method for glimepiride polymorphs.
Bonfilio R; Pires SA; Ferreira LM; de Almeida AE; Doriguetto AC; de Araújo MB; Salgado HR
J Pharm Sci; 2012 Feb; 101(2):794-804. PubMed ID: 22052673
[TBL] [Abstract][Full Text] [Related]
7. Insight into the solubility and dissolution behavior of piroxicam anhydrate and monohydrate forms.
Paaver U; Lust A; Mirza S; Rantanen J; Veski P; Heinämäki J; Kogermann K
Int J Pharm; 2012 Jul; 431(1-2):111-9. PubMed ID: 22554403
[TBL] [Abstract][Full Text] [Related]
8. Characterization of solid-state forms of mebendazole.
Kumar S; Chawla G; Sobhia ME; Bansal AK
Pharmazie; 2008 Feb; 63(2):136-43. PubMed ID: 18380400
[TBL] [Abstract][Full Text] [Related]
9. Dissolution and spectrophotometric determination of astaxanthin in aqueous solutions.
Tichý E; Zabka M; Gardavská K; Halenárová A; Scheerová ZK; Potúcková M
Pharmazie; 2011 Aug; 66(8):560-3. PubMed ID: 21901976
[TBL] [Abstract][Full Text] [Related]
10. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs.
Park SH; Choi HK
Int J Pharm; 2006 Sep; 321(1-2):35-41. PubMed ID: 16797892
[TBL] [Abstract][Full Text] [Related]
11. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
Fini A; Cavallari C; Ospitali F
Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
[TBL] [Abstract][Full Text] [Related]
12. Dissolution test for ivermectin in oral veterinary paste.
Sznitowska M; Pietkiewicz J; Stokrocka M; Janicki S
Pharmazie; 2004 Oct; 59(10):814-5. PubMed ID: 15544065
[TBL] [Abstract][Full Text] [Related]
13. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
[TBL] [Abstract][Full Text] [Related]
14. Towards a universal dissolution medium for carbamazepine.
El-Massik MA; Abdallah OY; Galal S; Daabis NA
Drug Dev Ind Pharm; 2006 Aug; 32(7):893-905. PubMed ID: 16908426
[TBL] [Abstract][Full Text] [Related]
15. Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties.
Zimmermann A; Millqvist-Fureby A; Elema MR; Hansen T; Müllertz A; Hovgaard L
Eur J Pharm Biopharm; 2009 Jan; 71(1):109-16. PubMed ID: 18619536
[TBL] [Abstract][Full Text] [Related]
16. Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole.
Brits M; Liebenberg W; de Villiers MM
J Pharm Sci; 2010 Mar; 99(3):1138-51. PubMed ID: 19691117
[TBL] [Abstract][Full Text] [Related]
17. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C.
Martins FT; Neves PP; Ellena J; Camí GE; Brusau EV; Narda GE
J Pharm Sci; 2009 Jul; 98(7):2336-44. PubMed ID: 18855910
[TBL] [Abstract][Full Text] [Related]
18. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
[TBL] [Abstract][Full Text] [Related]
19. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.
Overhoff KA; Engstrom JD; Chen B; Scherzer BD; Milner TE; Johnston KP; Williams RO
Eur J Pharm Biopharm; 2007 Jan; 65(1):57-67. PubMed ID: 16987642
[TBL] [Abstract][Full Text] [Related]
20. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant.
Sheng JJ; Kasim NA; Chandrasekharan R; Amidon GL
Eur J Pharm Sci; 2006 Nov; 29(3-4):306-14. PubMed ID: 16982177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]